# News & Resources Stay up to date with the latest news, publications, and resources from IXICO, covering neuroimaging science, clinical trial innovation, and company updates. # News & Resources Sources [News](/news-and-resources/news/) [Scientific Publications](/news-and-resources/publications/) [Webinars](/news-and-resources/webinars/) [Downloads](/news-and-resources/downloads/) [Blog](/news-and-resources/blog/) [ Sources ](javascript:void(0);) [News](/news-and-resources/news/) [Scientific Publications](/news-and-resources/publications/) [Webinars](/news-and-resources/webinars/) [Downloads](/news-and-resources/downloads/) [Blog](/news-and-resources/blog/) [ ![IXICO announces £2.7 million Phase 3 contract win in Huntington’s disease](/assets/blog-images/HD-contract-win__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/2-7-million-phase-3-contract-win-in-huntingtons-disease/) 2 Nov 26 news [ IXICO announces £2.7 million Phase 3 contract win in Huntington’s disease ](/news-and-resources/news/2-7-million-phase-3-contract-win-in-huntingtons-disease/) [ Read more ](/news-and-resources/news/2-7-million-phase-3-contract-win-in-huntingtons-disease/) [ ![IXICO presents research on novel methods to reduce unwanted variability in Huntington’s disease biomarker data ](/assets/blog-images/HD-novel-methods__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/ixico-presents-research-on-novel-methods-to-reduce-unwanted-variability-in-huntingtons-disease-biomarker-data/) 29 Oct 26 news [ Novel methods to reduce unwanted variability in Huntington’s disease biomarker data ](/news-and-resources/news/ixico-presents-research-on-novel-methods-to-reduce-unwanted-variability-in-huntingtons-disease-biomarker-data/) [ Read more ](/news-and-resources/news/ixico-presents-research-on-novel-methods-to-reduce-unwanted-variability-in-huntingtons-disease-biomarker-data/) [ ![Evaluating the Impact of Scanner Harmonisation with ComBat on Longitudinal Brain Volume Measures in Huntington’s Disease](/assets/blog-images/EHDN-2026-Poster__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/publications/new-blog-evaluating-the-impact-of-scanner-harmonisation-with-combat-on-longitudinal-brain-volume-measures-in-huntingtons-disease-post/) 29 Oct 26 publications [ Impact of Scanner Harmonisation on Longitudinal Brain Volume Measures in Huntington’s Disease ](/news-and-resources/publications/new-blog-evaluating-the-impact-of-scanner-harmonisation-with-combat-on-longitudinal-brain-volume-measures-in-huntingtons-disease-post/) [ Read more ](/news-and-resources/publications/new-blog-evaluating-the-impact-of-scanner-harmonisation-with-combat-on-longitudinal-brain-volume-measures-in-huntingtons-disease-post/) [ ![IXICO announces two contracts in Alzheimer's disease worth £1.5 million](/assets/blog-images/AD-contract-advancements__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/ixico-announces-two-contracts-in-alzheimers-disease-worth-1-5-million/) 22 Oct 26 news [ IXICO announces two contracts in Alzheimer's disease worth £1.5 million ](/news-and-resources/news/ixico-announces-two-contracts-in-alzheimers-disease-worth-1-5-million/) [ Read more ](/news-and-resources/news/ixico-announces-two-contracts-in-alzheimers-disease-worth-1-5-million/) [ ![IXICO announces 28% expected revenue growth for FY26](/assets/blog-images/Trading-update-FY26__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/ixico-trading-update-for-year-ending-30-september-2026/) 20 Oct 26 news [ IXICO announces 28% expected revenue growth for FY26 ](/news-and-resources/news/ixico-trading-update-for-year-ending-30-september-2026/) [ Read more ](/news-and-resources/news/ixico-trading-update-for-year-ending-30-september-2026/) [ ![Where Vascular Disease and Alzheimer’s Meet: Shared Pathways to Cognitive Decline ](/assets/blog-images/AD-Webinar-2026-1__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/webinars/where-vascular-disease-and-alzheimers-meet-shared-pathways-to-cognitive-decline/) 1 Oct 26 webinars [ Where Vascular Disease and Alzheimer’s Meet: Shared Pathways to Cognitive Decline ](/news-and-resources/webinars/where-vascular-disease-and-alzheimers-meet-shared-pathways-to-cognitive-decline/) [ Watch ](/news-and-resources/webinars/where-vascular-disease-and-alzheimers-meet-shared-pathways-to-cognitive-decline/) [ ![Neuromelanin-Sensitive MRI of the Substantia Nigra: Comparing TSE and MT-GRE Contrast](/assets/blog-images/ESMRMB-2026__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/publications/contrast-ratio-assessment-of-the-substantia-nigra-in-neuromelanin-sensitive-mri/) 1 Oct 26 publications [ Contrast ratio assessment of the substantia nigra in neuromelanin-sensitive MRI ](/news-and-resources/publications/contrast-ratio-assessment-of-the-substantia-nigra-in-neuromelanin-sensitive-mri/) [ Read more ](/news-and-resources/publications/contrast-ratio-assessment-of-the-substantia-nigra-in-neuromelanin-sensitive-mri/) [ ![IXICO to present advancements in neuroimaging for Parkinson’s disease at European radiology conference ](/assets/blog-images/advancements-in-neuroimaging-for-Parkinsons-disease__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/ixico-to-present-advancements-in-neuroimaging-for-parkinsons-disease/) 1 Oct 26 news [ IXICO to present advancements in neuroimaging for Parkinson’s disease ](/news-and-resources/news/ixico-to-present-advancements-in-neuroimaging-for-parkinsons-disease/) [ Read more ](/news-and-resources/news/ixico-to-present-advancements-in-neuroimaging-for-parkinsons-disease/) [ ![Beyond Diagnosis: 8 MRI and PET Biomarkers Shaping Alzheimer's Clinical Trials](/assets/blog-images/Alzheimers-biomarkers__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) ](/news-and-resources/blog/pet-mri-biomarkers-alzheimers-clinical-trials/) 29 Sep 26 blog [ Beyond Diagnosis: 8 MRI and PET Biomarkers Shaping Alzheimer's Clinical Trials ](/news-and-resources/blog/pet-mri-biomarkers-alzheimers-clinical-trials/) [ Read more ](/news-and-resources/blog/pet-mri-biomarkers-alzheimers-clinical-trials/) [ ![White matter hyperintensities: A precision neurology tool for Alzheimer’s patient stratification and improved trial sensitivity? ](/assets/blog-images/WMH-blog-title__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJqcGciLCJ3ZWJwIl0.webp) ](/news-and-resources/blog/white-matter-hyperintensities-a-precision-neurology-tool-for-alzheimers-patient-stratification-and-improved-trial-sensitivity/) 13 Jul 26 blog [ White Matter Hyperintensities: A precision neurology tool ](/news-and-resources/blog/white-matter-hyperintensities-a-precision-neurology-tool-for-alzheimers-patient-stratification-and-improved-trial-sensitivity/) [ Read more ](/news-and-resources/blog/white-matter-hyperintensities-a-precision-neurology-tool-for-alzheimers-patient-stratification-and-improved-trial-sensitivity/) [ ![IXICO EXPANDS RESEARCH COLLABORATIONS IN ALZHEIMER’S AND PARKINSON’S DISEASE](/assets/blog-images/IXICO-EXPANDS-RESEARCH-COLLABORATIONS-IN-ALZHEIMERS-AND-PARKINSONS-DISEASE-1__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJqcGciLCJ3ZWJwIl0.webp) ](/news-and-resources/news/ixico-expands-research-collaborations-in-alzheimers-and-parkinsons-disease/) 8 Jun 26 news [ IXICO EXPANDS RESEARCH COLLABORATIONS IN ALZHEIMER’S AND PARKINSON’S DISEASE ](/news-and-resources/news/ixico-expands-research-collaborations-in-alzheimers-and-parkinsons-disease/) [ Read more ](/news-and-resources/news/ixico-expands-research-collaborations-in-alzheimers-and-parkinsons-disease/) [ ![Neuromelanin MRI: An Early, Longitudinal Biomarker for Parkinson’s Disease](/assets/blog-images/Neuromelanin-Blog__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJqcGciLCJ3ZWJwIl0.webp) ](/news-and-resources/blog/neuromelanin-mri-an-early-longitudinal-biomarker-for-parkinsons-disease/) 4 Jun 26 blog [ Neuromelanin MRI: An Early, Longitudinal Biomarker for Parkinson’s Disease ](/news-and-resources/blog/neuromelanin-mri-an-early-longitudinal-biomarker-for-parkinsons-disease/) [ Read more ](/news-and-resources/blog/neuromelanin-mri-an-early-longitudinal-biomarker-for-parkinsons-disease/) [1](javascript:void(0);) [2](/news-and-resources/index.md?start=12) [3](/news-and-resources/index.md?start=24) [4](/news-and-resources/index.md?start=36) [5](/news-and-resources/index.md?start=48) [...](javascript:void(0);) [13](/news-and-resources/index.md?start=144) [Prev](javascript:void(0);) [Next](/news-and-resources/index.md?start=12) 1 - 12 of 155 results ### Ixico News on Proactive [IXICO lands £2.7m Huntington’s disease trial contract, second win in a year - ICYMI November 7th 2026 06:10 AM](https://www.proactiveinvestors.com/companies/news/1101091/ixico-lands-2-7m-huntington-s-disease-trial-contract-second-win-in-a-year-icymi-1101091.html) [IXICO CEO on £2.7m Huntington’s disease trial contract win; second in a year November 2nd 2026 12:40 PM](https://www.proactiveinvestors.com/companies/news/1101064/ixico-ceo-on-2-7m-huntington-s-disease-trial-contract-win-second-in-a-year-1101064.html) [IXICO retains 'buy' rating from Cavendish after £2.7m Huntington’s disease contract win November 2nd 2026 10:30 AM](https://www.proactiveinvestors.com/companies/news/1101053/ixico-retains-buy-rating-from-cavendish-after-2-7m-huntington-s-disease-contract-win-1101053.html) [IXICO, IP Group, Helium One Global, Plexus, Tower Resources, Quadrise - Small Cap Snapshot November 2nd 2026 09:25 AM](https://www.proactiveinvestors.com/companies/news/1101059/ixico-ip-group-helium-one-global-plexus-tower-resources-quadrise-small-cap-snapshot-1101059.html) [IXICO wins £2.7m Huntington’s disease trial contract November 2nd 2026 07:33 AM](https://www.proactiveinvestors.com/companies/news/1101040/ixico-wins-2-7m-huntington-s-disease-trial-contract-1101040.html) [IXICO research challenges assumption that cutting scanner variability always improves Huntington's tracking October 29th 2026 07:37 AM](https://www.proactiveinvestors.com/companies/news/1100897/ixico-research-challenges-assumption-that-cutting-scanner-variability-always-improves-huntington-s-tracking-1100897.html) [IXICO shares jump 19% as revenue growth and order book strengthen October 20th 2026 09:30 AM](https://www.proactiveinvestors.com/companies/news/1100380/ixico-shares-jump-19-as-revenue-growth-and-order-book-strengthen-1100380.html) [IXICO expects 28% revenue growth as orders accelerate October 20th 2026 06:26 AM](https://www.proactiveinvestors.com/companies/news/1100359/ixico-expects-28-revenue-growth-as-orders-accelerate-1100359.html) [IXICO CEO on strong FY26 - revenue up 28% and cash at £10.4m as TechBio strategy gathers pace October 20th 2026 06:15 AM](https://www.proactiveinvestors.com/companies/news/1100356/ixico-ceo-on-strong-fy26-revenue-up-28-and-cash-at-10-4m-as-techbio-strategy-gathers-pace-1100356.html) [IXICO targets growth with AI-powered neuroscience - One2One Investor Forum October 2nd 2026 07:27 AM](https://www.proactiveinvestors.com/companies/news/1099500/ixico-targets-growth-with-ai-powered-neuroscience-one2one-investor-forum-1099500.html) [MARKETS LIVE: Wall Street closes mostly higher after sharp rise in Treasury yields October 1st 2026 20:15 PM](https://www.proactiveinvestors.com/companies/news/1099420/markets-live-wall-street-closes-mostly-higher-after-sharp-rise-in-treasury-yields-1099420.html) [IXICO presents Parkinson's research showing improved brain imaging contrast October 1st 2026 07:15 AM](https://www.proactiveinvestors.com/companies/news/1099431/ixico-presents-parkinson-s-research-showing-improved-brain-imaging-contrast-1099431.html) [IXICO guidance unchanged after Huntington's cancellations July 13th 2026 06:37 AM](https://www.proactiveinvestors.com/companies/news/1095316/ixico-guidance-unchanged-after-huntington-s-cancellations-1095316.html) [IXICO lifts revenue forecast on contract wins and wider client base - UPDATE July 7th 2026 09:10 AM](https://www.proactiveinvestors.com/companies/news/1095020/ixico-lifts-revenue-forecast-on-contract-wins-and-wider-client-base-update-1095020.html) [ IXICO strengthens Alzheimer's and Parkinson's advisory board with world-class experts June 8th 2026 13:55 PM](https://www.proactiveinvestors.com/companies/news/1093589/ixico-strengthens-alzheimer-s-and-parkinson-s-advisory-board-with-world-class-experts-1093589.html) Updated: 0 minute 0 seconds ago ## Sign-up to the latest from IXICO